Literature DB >> 6565516

Natural cytotoxicity in lymphatic metastasis. I. In vitro studies using the rat tumor BSp73 and its variants.

S Matzku, H P Oberneder, R Keller, M Zöller.   

Abstract

Serial transplantation of primary BSp73 ascites cells to a subcutaneous (SC) site gave rise to the appearance of two solid variants differing in their capacity to metastasize via the lymphatics. Tissue cultures derived from variant AS (nonmetastasizing) showed epithelioid morphology, while cultures derived from variant ASML (metastatic) showed spherical morphology. Upon cloning, both variants proved to be operationally homogeneous. Susceptibility of cultured BSp73 cells to NK and macrophage-mediated cytotoxicity was closely correlated to morphology, inasmuch as epithelioid cells were susceptible, while spherical cells were resistant, to lysis. With stimulated effector cells a general increase in cytotoxicity was observed, but epithelioid cells still showed a higher susceptibility level. Resistance of ASML-type cells to natural cytotoxicity was not due to the lack of recognition structures or to a general increase in the mechanical stability of spherical cells. This was concluded from cold target inhibition and from hypotonic shock treatment experiments, respectively.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6565516     DOI: 10.1007/bf00200044

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  41 in total

1.  Characterization of cloned cytotoxic lymphocytes with NK-like activity.

Authors:  H Acha-Orbea; P Groscurth; R Lang; L Stitz; H Hengartner
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

2.  Differential effects of various pharmacological agents on the cytolytic reaction mechanism of the human natural killer lymphocyte: further resolution of programming for lysis and KCIL into discrete stages.

Authors:  J C Hiserodt; L J Britvan; S R Targan
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

3.  Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse.

Authors:  J C Roder; R Kiessling
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

4.  Metabolic inhibitors render "resistant" target cells sensitive to natural killer cell-mediated lysis.

Authors:  L A Kunkel; R M Welsh
Journal:  Int J Cancer       Date:  1981-01-15       Impact factor: 7.396

5.  Natural killer cells kill tumour cells at a given stage of differentiation.

Authors:  M Gidlund; A Orn; P K Pattengale; M Jansson; H Wigzell; K Nilsson
Journal:  Nature       Date:  1981-08-27       Impact factor: 49.962

6.  Augmentation of cell-mediated cytotoxicity to a rat lymphoma. II. Characterization of the non-T cytotoxic cells stimulated in vivo by tumour cells as natural killer cells.

Authors:  H J Dawkins; G R Shellam
Journal:  Int J Cancer       Date:  1979-08       Impact factor: 7.396

7.  Active tumor cell resistance to human natural killer lymphocyte attack.

Authors:  D Hudig; M Djobadze; D Redelman; J Mendelsohn
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

8.  Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice.

Authors:  N Hanna; I J Fidler
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

9.  Variation in selectivity of tumor cell cytolysis by murine macrophages, macrophage-like cell lines and NK cells.

Authors:  R H Wiltrout; M J Brunda; H T Holden
Journal:  Int J Cancer       Date:  1982-09-15       Impact factor: 7.396

10.  Role of natural killer cells in the destruction of circulating tumor emboli.

Authors:  N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

View more
  5 in total

1.  Natural cytotoxicity in lymphatic metastasis. II. In vivo studies with BSp73 variants differing in metastatic capacity.

Authors:  S Matzku
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

2.  IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Authors:  M Zöller
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

3.  Substrate adhesiveness and experimental metastatic potential of rat ascites hepatoma AH7974-derived variant sublines.

Authors:  T Kawaguchi; S Igarashi; H Wakabayashi; S Yokoya; K Fukui
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

4.  Changes in adhesive properties of tumor cells do not necessarily influence metastasizing capacity.

Authors:  M Zöller; S Matzku
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

5.  Tumor-exosomes and leukocyte activation: an ambivalent crosstalk.

Authors:  Daniela Zech; Sanyukta Rana; Markus W Büchler; Margot Zöller
Journal:  Cell Commun Signal       Date:  2012-11-28       Impact factor: 5.712

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.